3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
2
Thoracic
1
Plasma cell
1
Head & Neck
1
Gastrointestinal
1
Conditions
Squamous Cell Carcinoma of Head and Neck
143
Head and Neck Neoplasms
121
Carcinoma, Non-Small-Cell Lung
51
Thyroid Neoplasms
43
Melanoma
37
Nasopharyngeal Carcinoma
35
Mouth Neoplasms
35
Ovarian Neoplasms
32
Colorectal Neoplasms
31
Breast Neoplasms
31
Oropharyngeal Neoplasms
30
Neoplasm Metastasis
26
Uterine Cervical Neoplasms
25
Lung Neoplasms
24
Carcinoma, Squamous Cell
21
Carcinoma, Renal Cell
21
Stomach Neoplasms
20
Neoplasms
20
Carcinoma
19
Esophageal Neoplasms
18
Pancreatic Neoplasms
17
Triple Negative Breast Neoplasms
16
Prostatic Neoplasms
16
Laryngeal Neoplasms
16
Endometrial Neoplasms
16
Sarcoma
15
Urinary Bladder Neoplasms
14
Hypopharyngeal Neoplasms
12
Carcinoma, Transitional Cell
12
Salivary Gland Neoplasms
11
Interventions
pembrolizumab
1
Histamine H2 Antagonists
1
Famotidine
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Solitary Fibrous Tumors
×
Head & Neck
×
30 days
×
Clear all
NCT06789172
2026-05-22
INVOKE
Epkin
Phase 1
Recruiting
166 enrolled